Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
16.40
+0.25 (1.55%)
Dec 4, 2024, 1:56 PM EST - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.44 billion as of December 4, 2024. Its market cap has increased by 173.80% in one year.
Market Cap
5.44B
Enterprise Value
5.38B
1-Year Change
173.80%
Ranking
Category
Stock Price
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.44B, an increase of 4,618.53%. That is a compound annual growth rate of 72.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inspire Medical Systems | 5.78B |
| Krystal Biotech | 5.68B |
| Grifols | 5.64B |
| Ionis Pharmaceuticals | 5.64B |
| Stevanato Group | 5.47B |
| Waystar Holding | 5.31B |
| Crinetics Pharmaceuticals | 5.30B |
| PROCEPT BioRobotics | 5.17B |